L. P. Ta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
L. P. Ta has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
H. Abeysekera
Department of Biomedical Sciences, School of Infection, Inflammation and Immunology, University of Birmingham, Edgbaston, Birmingham, UK
1 shared publication- Richard David Horniblow
Department of Biomedical Sciences, School of Infection, Inflammation, & Immunology, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; Birmingham NIHR Biomedical Research Centre in Inflammation, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
1 shared publication S. Corrigan
Department of Biomedical Sciences, School of Infection, Inflammation and Immunology, University of Birmingham, Edgbaston, Birmingham, UK
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 22 January 2026
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 12 (1) , 37
Extremely oxygen-sensitive next-generation probiotics: can current microcomposite formulations ensure effective colonic delivery?
This narrative review evaluates the suitability of conventional biopolymer-based microencapsulation strategies, originally developed for facultative and aerotolerant probiotics, for the protection and delivery of extremely oxygen-sensitive (EOS) next-generation probiotics (NGPs). With increasing interest in NGPs, there is a pressing need to establish whether conventional formulation approaches can be effectively translated for these highly oxygen-sensitive bioactives. We reviewed commonly used microencapsulation materials and techniques, assessing their suitability and potential to preserve EOS bacterial viability. Hydrated pectin- and gellan-based microcomposite systems, particularly when combined with xanthan gum or other polymers, exhibited the strongest oxygen-protection performance. In contrast, alginate alone demonstrated inconsistent barrier properties, though its performance improved when blended or coated with chitosan. Dehydrated microcomposite systems did not yield additional viability benefits compared to their hydrated counterparts. Importantly, none of the studies explicitly quantified oxygen exposure parameters or established threshold levels required for effective protection of EOS strains. Despite some microcomposite systems demonstrating potential for EOS colonic delivery, our findings highlight a critical gap in formulation science for these sensitive bioactives and underscore the need for the development of bespoke, tailored delivery systems that advance beyond conventional approaches designed for facultative or aerotolerant strains. Addressing these gaps will support the advancement of microencapsulation technologies, improve biotherapeutic NGP formulation, and ultimately facilitate the translation of exploratory clinical findings into rationally designed, accessible, and effective microbiome-based interventions.
- 22 January 2026
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 12 (1) , 37
Top Cited PapersOpen AccessExtremely oxygen-sensitive next-generation probiotics: can current microcomposite formulations ensure effective colonic delivery?
This narrative review evaluates the suitability of conventional biopolymer-based microencapsulation strategies, originally developed for facultative and aerotolerant probiotics, for the protection and delivery of extremely oxygen-sensitive (EOS) next-generation probiotics (NGPs). With increasing interest in NGPs, there is a pressing need to establish whether conventional formulation approaches can be effectively translated for these highly oxygen-sensitive bioactives. We reviewed commonly used microencapsulation materials and techniques, assessing their suitability and potential to preserve EOS bacterial viability. Hydrated pectin- and gellan-based microcomposite systems, particularly when combined with xanthan gum or other polymers, exhibited the strongest oxygen-protection performance. In contrast, alginate alone demonstrated inconsistent barrier properties, though its performance improved when blended or coated with chitosan. Dehydrated microcomposite systems did not yield additional viability benefits compared to their hydrated counterparts. Importantly, none of the studies explicitly quantified oxygen exposure parameters or established threshold levels required for effective protection of EOS strains. Despite some microcomposite systems demonstrating potential for EOS colonic delivery, our findings highlight a critical gap in formulation science for these sensitive bioactives and underscore the need for the development of bespoke, tailored delivery systems that advance beyond conventional approaches designed for facultative or aerotolerant strains. Addressing these gaps will support the advancement of microencapsulation technologies, improve biotherapeutic NGP formulation, and ultimately facilitate the translation of exploratory clinical findings into rationally designed, accessible, and effective microbiome-based interventions.